Recursion Pharmaceuticals (RXRX) Return on Capital Employed [ROCE] (2021 - 2026)
Recursion Pharmaceuticals' Return on Capital Employed [ROCE] came in at -47.05% for Q2 2026, up 9.95 percentage points from -57.00% a year earlier but down 1.22 percentage points from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals' Return on Capital Employed [ROCE] was -49.34%, up 6.12 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a four-year change of -4.52 percentage points (FY2021 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -55.46% in FY2024 (+4.45 pp), -59.91% in FY2023 (-15.68 pp), -44.23% in FY2022 (+0.59 pp) and -44.82% in FY2021.
- The five-year range for quarterly Return on Capital Employed [ROCE] is -70.80% (Q1 2024) to -22.56% (Q3 2021).
- Year-over-year, Return on Capital Employed [ROCE] has increased for seven consecutive quarters, with an average year-over-year change of +6.90 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 24.31 percentage points), and the weakest in Q1 2024 (a drop of 25.42 percentage points).
- Business Quant data shows RXRX's Return on Capital Employed [ROCE] at -45.83% (Q1 2026), -50.28% (Q4 2025) and -60.51% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Recursion Pharmaceuticals | 2.17 Bn | -429.42 Mn | -3.82 Mn | -47.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.05% |
| Mar 31, 2026 | -45.83% |
| Dec 31, 2025 | -50.28% |
| Sep 30, 2025 | -60.51% |
| Jun 30, 2025 | -57.00% |
| Mar 31, 2025 | -46.48% |
| Dec 31, 2024 | -53.22% |
| Sep 30, 2024 | -61.37% |
| Jun 30, 2024 | -68.08% |
| Mar 31, 2024 | -70.80% |
| Dec 31, 2023 | -63.75% |
| Sep 30, 2023 | -56.27% |
| Jun 30, 2023 | -51.61% |
| Mar 31, 2023 | -45.37% |
| Dec 31, 2022 | -44.18% |
| Sep 30, 2022 | -44.67% |
| Jun 30, 2022 | -38.49% |
| Mar 31, 2022 | -35.50% |
| Dec 31, 2021 | -31.09% |
| Sep 30, 2021 | -22.56% |
API Access
Recursion Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();